Sign Up Today and Learn More About LevitasBio Stock

Invest in or calculate the value of your shares in LevitasBio or other pre-IPO companies through EquityZen's platform.

Get Started

LevitasBio Stock

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

About LevitasBio Stock

Founded

2017

Headquarters

San Francisco, CA, US

Levitas is redefining cellular analytics with its novel platform of magnetic levitation technology. Their disruptive technology overcomes the current technological limitations of cellular analysis by providing label-free, simple, and universal methods of analysis. The company's platform, the LeviCell enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing.

LevitasBio Press Mentions

Stay in the know about the latest news on LevitasBio

LevitasBio Management

Leadership team at LevitasBio

CEO

Martin Pieprzyk

Scientific Co-Founder

Lars Steinmetz

Locked Features

Join now and verify your accreditation status to gain access to:

  • LevitasBio current valuation
  • LevitasBio stock price
  • Available deals in LevitasBio and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in LevitasBio stock?

Accredited investors can buy pre-IPO stock in companies like LevitasBio through EquityZen funds. These investments are made available by existing LevitasBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell LevitasBio stock?

Shareholders can sell their LevitasBio stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."